The role of vitamins and minerals in modulating the expression of microRNA

Nutrition Research Reviews

Volumn 27, Issue 1, 2014, Pages 94-106

  Beckett, Emma L ^a,b   Yates, Zoe ^c   Veysey, Martin ^d   Duesing, Konsta ^b   Lucock, Mark ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Teaching and Research Unit   (Australia)

Author keywords

Micronutrients; MicroRNA; Minerals; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM; ASCORBIC ACID; FOLIC ACID; IRON; MAGNESIUM; METHYL GROUP; MICRORNA; MINERAL; RETINOIC ACID; SELENIUM; TRACE ELEMENT; VITAMIN; VITAMIN D; ZINC; ALUMINUM SULFATE; CALCITRIOL; DECITABINE; DNA; FERROUS SULFATE; HISTONE; MICRORNA 1; MICRORNA 100; MICRORNA 125B; MICRORNA 126; MICRORNA 132; MICRORNA 203; MICRORNA 205; MICRORNA 22; MICRORNA 627; MICRORNA 9; PLANT RNA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D RECEPTOR; DNA METHYLTRANSFERASE 1; UNTRANSLATED RNA;

ARTICLE; CIRCULATION; EPIGENETICS; FOOD; GENE EXPRESSION; HUMAN; METABOLISM; MODULATION; NONHUMAN; ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ASCORBIC ACID DEFICIENCY; BIOGENESIS; BREAST CANCER; CANCER PREVENTION; CARBON METABOLISM; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROTECTION; CELL STRESS; COLON CANCER; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY MODIFICATION; DISEASE COURSE; DNA METHYLATION; DNA MODIFICATION; DRUG RECEPTOR BINDING; EPIGENOME; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE TARGETING; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HISTONE MODIFICATION; HORMONAL REGULATION; INFLAMMATORY DISEASE; LEUKEMIA; LIVER CELL CARCINOMA; MACRONUTRIENT; METABOLOME; MOLECULAR NUTRITION; NEOPLASM; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NUTRITION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHENOTYPE; PROMYELOCYTIC LEUKEMIA; PROPHYLAXIS; PROSTATE CANCER; REVIEW; RISK FACTOR; RNA PROCESSING; RNA TRANSLATION; SELENIUM DEFICIENCY; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ZINC DEFICIENCY; CELL PROLIFERATION; DNA REPAIR; DNA SEQUENCE; DNA SYNTHESIS; GENE CONTROL; GENE PRODUCT; MICRORNA MODULATION; MOLECULAR GENETICS; VITAMIN SUPPLEMENTATION; GENETIC EPIGENESIS;

DIET; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MINERALS; TRACE ELEMENTS; VITAMINS;

EID: 84903882836     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422414000043     Document Type: Article

References (167)

1. Papageorgiou N, Tousoulis D, Androulakis E, et al. (2012) The role of microRNAs in cardiovascular disease. Curr Med Chem 19, 2605-2610.
2. Lorenzen J, Kumarswamy R, Dangwal S, et al. (2012) Micro-RNAs in diabetes and diabetes-Associated complications. RNA Biol 9, 820-827.
3. Calin G & Croce C (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866. (Pubitemid 44629897)
4. Lee R, Feinbaum R & Ambros V (1993) The C. elegans het-erochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. (Pubitemid 24014542)
5. Ruvkun G (2001) Glimpses of a tiny RNA world. Molecular Biology 294, 797-799.
6. Selbach M, Schwanhausser B, Thierfelder T, et al. (2008) Widespread changes in protein synthesis induced by micro-RNAs. Nature 455, 64-71.
7. Brennecke J, Stark A, Russell R, et al. (2005) Principles of microRNA-target recognition. PLoS Biol 3, e85.
8. Friedman R, Farh K, Burge C, et al. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105.
9. Ariel D & Upadhyay D (2012) The role and regulation of microRNAs in asthma. Curr Opin Allergy Clin Immunol 12, 49-52.
10. Wang H, Peng W, Ouyang X, et al. (2012) Circulating micro-RNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160, 198-206.
11. Weiland M, Gao X, Zhou L, et al. (2012) Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 9, 850-859.
12. Gilad S, Meiri E, Yogev Y, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3, e3148.
13. Bartel D (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
14. Patil V, Zhou R & Rana T (2014) Gene regulation by non-coding RNAs. Crit Rev Biochem Mol Biol 49, 16-32.
15. Yekta S, Shih I & Bartel D (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304, 594-596. (Pubitemid 38541919)
16. Davis E, Caiment F, Tordoir X, et al. (2005) RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 15, 743-749. (Pubitemid 40599929)
17. Chendrimada T, Finn K, Ji X, et al. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823-828. (Pubitemid 46920131)
18. Petersen C, Bordeleau M, Pelletier J, et al. (2006) Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21, 533-542. (Pubitemid 43228008)
19. Wu L, Fan J & Belasco J (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 103, 4034-4039.
20. Vasudevan S, Tong Y & Steitz J (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
21. Orom U, Nielsen F & Lund A (2008) MicroRNA-10a binds the 50UTR of ribosomal protein mRNAs and enhances their translation. Cell 30, 460-471. (Pubitemid 351672378)
22. Place R, Li L, Pookot D, et al. (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105, 1608-1613. (Pubitemid 351346562)
23. Vasudevan S (2012) Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA 3, 311-330.
24. Weichenhan D & Plass C (2013) The evolving epigenome. Hum Mol Genet 22, R1-R6.
25. Chuang J & Jones P (2007) Epigenetics and microRNAs. Pediatr Res 61, 24R-29R. (Pubitemid 46653064)
26. Saetrom P, Snøve OJ & Rossi J (2007) Epigenetics and microRNAs. Pediatr Res 61, 17R-23R. (Pubitemid 46653063)
27. Sato F, Tsuchiya S, Meltzer S, et al. (2011) MicroRNAs and epigenetics. FEBS J 278, 1598-1609.
28. Berger S, Kouzarides T, Shiekhattar R, et al. (2009) An operational definition of epigenetics. Genes Dev 23, 781-783.
29. Park L, Friso S & Choi S (2012) Nutritional influences on epi-genetics and age-related disease. Proc Nutr Soc 71, 75-83.
30. Jaenisch R & Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33, 245-254. (Pubitemid 36278835)
31. Deaton A & Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25, 1010-1022.
32. Das C & Tyler J (2012) Histone exchange and histone modifications during transcription and aging. Biochim Biophys Acta 1819, 332-342.
33. Costello J, Krzywinski M & Marra M (2009) A first look at entire human methylomes. Nat Biotechnol 27, 1130-1132.
34. Christensen B, Houseman E, Marsit C, et al. (2009) Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5, e1000602.
35. Fabbri M & Calin G (2010) Epigenetics and miRNAs in human cancer. Adv Genet 70, 87-99.
36. Martello G, Rosato A, Ferrari F, et al. (2010) A microRNA targeting dicer for metastasis control. Cell 141, 1195-1207.
37. Lujambio A, Calin G, Villanueva A, et al. (2008) A microRNA DNA methylation signature for human metastasis. Proc Natl Acad Sci U S A 105, 13556-13561.
38. Lujambio A & Esteller M (2009) How epigenetics can explain human metastisis: a new role for microRNAs. Cell Cycle 8, 377-382.
39. Saito Y, Liang G, Egger G, et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin modifiying drugs in human cancer cells. Cancer Cell 9, 435-443. (Pubitemid 43832188)
40. Guan P, Yin Z, Li X, et al. (2012) Meta-Analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 31, 54.
41. Lehmann U, Hasemeier B, Christgen M, et al. (2008) Epige-netic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214, 17-24.
42. Datta J, Kutay H, Nasser M, et al. (2008) Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68, 5049-5058.
43. Nebbioso A, Carafa V, Benedetti R, et al. (2012) Trials with 'epigenetic' drugs: an update. Mol Oncol 6, 657-682.
44. Nasser M, Datta J, Nuovo G, et al. (2008) Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitiz-Ation to doxorubicin-induced apotosis by miR-1. J Biol Chem 283, 33394-33405.
45. Scott G, Mattie M, Berger C, et al. (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66, 1277-1281. (Pubitemid 43259904)
46. Wada T, Kikuchi J & Furukawa Y (2012) Histone deacety-lase 1 enhances microRNA processing via deacetylation of DGCR8. EMBO Rep 13, 142-149.
47. Fabbri M, Garzon R, Cimmino A, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferase 3A and 3B. Proc Natl Acad Sci U S A 104, 15805-15810. (Pubitemid 350035380)
48. Garzon R, Liu S, Fabbri M, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumour suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectlty DNMT1. Blood 113, 6411-6418.
49. Zhao S, Wang Y, Liang Y, et al. (2011) MicroRNA-126 regulates DNA methylation in CD4+T cells and contributes to systemic lupus erythematosus by targeting DNA methyl-transferase 1. Arthritis Rheum 63, 1376-1386.
50. Pan W, Zhu S, Yuan M, et al. (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184, 6773-6781.
51. Duursma A, Kedde M, Schrier M, et al. (2008) miR-148 targets human DNMR3b protein coding region. RNA Biol 14, 872-877. (Pubitemid 351574909)
52. Sander S, Bullinger L, Klapproth K, et al. (2008) MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 112, 4202-4212.
53. Varambally S, Cao Q, Mani R, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyl-transferase EZH2 in cancer. Science 322, 1695-1699.
54. Friedman J, Liang G, Liu C, et al. (2009) The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69, 2623-2629.
55. Gandellini P, Folini M, Longoni N, et al. (2009) miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Ce. Cancer Res 69, 2287-2295.
56. Juan A, Kumar R, Marx J, et al. (2009) miR-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36, 61-74.
57. Fan D, Tsang F, Tam A, et al. (2013) Histone lysine methyl-transferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b. Hepatology 57, 637-647.
58. Sluijter J, van Mil A, van Vliet P, et al. (2010) MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 30, 859-868.
59. Zhao Y, Ransom J, Li A, et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317. (Pubitemid 46574975)
60. Chen J-F, Mandel E, Thomson J, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38, 228-233. (Pubitemid 43177239)
61. Song B, Wang Y, Xi Y, et al. (2009) Mechanism of chemore-sistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28, 4065-4074.
62. Noonan E, Place R, Pookot D, et al. (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28, 1717-1724.
63. Buurman R, Gürlevik E, Schäffer V, et al. (2012) Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143, 811-820e15.
64. Roccaro A, Sacco A, Jia X, et al. (2010) MicroRNA-dependent modulation of histone acetylation in Walden-strom macroglobulinemia. Blood 116, 1506-1514.
65. Barker D (1995) Fetal origins of coronary heart disease. BMJ 311, 171-174.
66. Barker D (1995) Intrauterine programming of adult disease. Mol Med Today 1, 418-423.
67. Barker D, Winter P, Osmond C, et al. (1989) Weight in infancy and death from ischaemic heart disease. Lancet ii, 577-580. (Pubitemid 19216205)
68. Canani R, Costanzo M, Leone L, et al. (2011) Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 24, 198-205.
69. Tobi E, Slagboom P, van Dongen J, et al. (2012) Prenatal famine and genetic variation are independently and addi-tively associated with DNA methylation at regulatory loci within IGF2/H19. PLOS ONE 7, e37933.
70. Lumey L, Terry M, Delgado-Cruzata L, et al. (2012) Adult global DNA methylation in relation to pre-natal nutrition. Int J Epidemiol 41, 116-123.
71. Heijmans B, Tobi E, Stein A, et al. (2008) Persistent epige-netic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105, 17046-17049.
72. Fraga M, Ballestar E, Paz M, et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102, 10604-10609. (Pubitemid 41061601)
73. Mill J, Dempster E, Caspi A, et al. (2006) Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet 141B, 421-425. (Pubitemid 43872897)
74. Talens R, Christensen K, Putter H, et al. (2012) Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell 11, 694-703.
75. Zhao J, Goldberg J & Vaccarino V (2013) Promoter methylation of serotonin transporter gene is associated with obesity measures: a monozygotic twin study. Int J Obes (Lond) 37, 140-145.
76. Roberts C & Barnard R (2005) Effects of exercise and diet on chronic disease. J Appl Physiol 98, 3-30. (Pubitemid 40044843)
77. World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series no. 916. Geneva: WHO.
78. Teunissen S, Wesker W, Kruitwagen C, et al. (2007) Symptom prevalance in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34, 94-104. (Pubitemid 46970881)
79. Witwer K (2012) Xenomirs and miRNA homeostasis in health and disease. RNA Biol 9, 1147-1154.
80. Lundstrom K (2012) MicroRNA and diet in disease prevention and treatment. J Med Res Sci 2, 11-18.
81. McKay J & Mathers J (2011) Diet induced epigenetic changes and their implications for health. Acta Physiol (Oxf) 202, 103-118.
82. Pittas A, Lau J, Hu F, et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-Analysis. J Clin Endocrinol Metab 92, 2017-2029. (Pubitemid 46997093)
83. Wang T, Pencina M, Booth S, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
84. Adorini L (2008) Penna G Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheu-matol 4, 404-412.
85. Lappe J, Travers-Gustafson D, Davies K, et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586-1591. (Pubitemid 46890428)
86. Lamprecht S & Lipkin M (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3, 601-614. (Pubitemid 37328832)
87. Carlberg C (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164, 29-42.
88. Sonkoly E, Lovén J, Xu N, et al. (2012) MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis 1, e3.
89. Giangreco A, Vaishnav A, Wagner D, et al. (2013) Tumor suppressor microRNAs, miR-100 and-125b, are regulated by 1, 25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Cancer Prev Res (Phila) 6, 483-494.
90. Essa S, Reichrath S, Mahlknecht U, et al. (2012) Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res 32, 383-389.
91. Essa S, Denzer N, Mahlknecht U, et al. (2010) VDR micro-RNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J Steroid Biochem Mol Biol 121, 110-113.
92. Alvarez-Díaz S, Valle N, Ferrer-Mayorga G, et al. (2012) MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet 21, 2157-2165.
93. Mohri T, Nakajima M, Takagi S, et al. (2009) MicroRNA regulates human vitamin D receptor. Int J Cancer 125, 1328-1333.
94. Zhang J, Yang Y, Yang T, et al. (2010) MicroRNA-22, down-regulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigeni-city. Br J Cancer 103, 1215-1220.
95. Lee J, Jeong W, Lim W, et al. (2013) Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen. PLOS ONE 8, e61658.
96. Padi S, Zhang Q, Rustum Y, et al. (2013) MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145, 437-446.
97. Ting H, Messing J, Yasmin-Karim S, et al. (2013) Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. J Biol Chem 288, 1-9.
98. Guan H, Liu C, Chen Z, et al. (2013) 1, 25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells. Gene 522, 142-146.
99. Wang X, Gocek E, Liu C, et al. (2009) MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1, 25-dihydroxyvitamin D3. Cell Cycle 8, 736-741.
100. Peng X, Vaishnav A, Murillo G, et al. (2010) Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem 110, 1324-1333.
101. Fulda S, Gorman A, Hori O, et al. (2010) Cellular stress responses: cell survival and cell death. Int J Cell Biol 2010, 214074.
102. Jia Y, Cong R, Li R, et al. (2012) Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver. J Nutr 142, 1659-1665.
103. Jorde R, Svartberg J, Joakimsen R, et al. (2012) Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes 5, 245.
104. Enquobahrie D, Williams M, Qiu C, et al. (2011) Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxy-vitamin D concentrations. J Matern Fetal Neonatal Med 24, 1002-1012.
105. Nowson C, McGrath J, Ebeling P, et al. (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 196, 686-687.
106. Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71, 121-138.
107. Lucock M & Daskalakis I (2000) New perspectives on folate status: a differential role for the vitamin in cardiovascular disease, birth defects and other conditions. Br J Biomed Sci 57, 254-260.
108. Lianga Y, Lib Y, Liub Z, et al. (2012) Mechanism of folate deficiency-induced apoptosis in mouse embryonic stem cells: cell cycle arrest/apoptosis in G1/G0 mediated by microRNA-302a and tumor suppressor gene Lats2. Int J Biochem Cell Biol 44, 1750-1760.
109. Marsit C, Eddy K & Kelsey K (2006) MicroRNA responses to cellullar stress. Cancer Res 66, 10843-10848.
110. Tryndyak V, Ross S, Beland F, et al. (2009) Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 48, 479-487.
111. Pogribny I, Ross S, Wise C, et al. (2006) Irreversible global DNA hypomethylation as a key step in hepatocarcinogen-esis induced by dietary methyl deficiency. Mutat Res 593, 80-87. (Pubitemid 43113364)
112. Kutay H, Bai S, et al. (2006) Datta J,./i} Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99, 671-678. (Pubitemid 44521987)
113. Pogribny I, Tryndyak V, Ross S, et al. (2008) Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutr Rev 66, Suppl. 1, S33-S35.
114. Wang B, Majumder S, Nuovo G, et al. (2009) Role of micro-RNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL6 mice. Hepatology 50, 1152-1161.
115. Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134, 921-931.
116. Kawasaki H & Taira K (2003) Functional analysis of microRNAs during retinoic acid-induced neuronal differentiation of human NT2 cells. Nucleic Acid Res Suppl 26, 243-244.
117. Annibali D, Gioia U, Savino M, et al. (2012) A new module in neural differentiation control: two microRNAs upregu-lated by retinoic acid, miR-9 and-103, target the differentiation inhibitor ID2. PLOS ONE 7, e40269.
118. Das S, Foley N, Bryan K, et al. (2010) MicroRNAmediatesDNA demethylation events triggered by retinoic acid during neuro-blastoma cell differentiation. Cancer Res 70, 7874-7881.
119. Beveridge N, Tooney P, Carroll A, et al. (2009) Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell Signal 21, 1837-1845.
120. Zhao J, Sun D, Wang J, et al. (2008) Retinoic acid downre-gulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Childs Nerv Syst 24, 495-492.
121. Cloonan N, Brown M, Steptoe A, et al. (2008) The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9, R127.
122. Yang F, Yin Y, Wang F, et al. (2010) miR-17-5p promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-Activated protein kinase-heat shock protein 27 pathway. Hepatology 51, 1614-1623.
123. Wang X, Gong JN, Yu J, et al. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119, 4992-5004.
124. Jian P, Li Z, Fang T, et al. (2011) Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hema-tol Oncol 4, 20.
125. Garzon R, Pichiorri F, Palumbo T, et al. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26, 4148-4157. (Pubitemid 46920170)
126. Rossi A, D'Urso O, Gatto G, et al. (2010) Non-coding RNAs change their expression profile after retinoid induced differentiation of the promyelocytic cell line NB4. BMC Res Notes 3, 24.
127. Juraschek S, Guallar E, Appel L, et al. (2012) Effects of vitamin C supplementation on blood pressure: a meta-Analysis of randomized controlled trials. Am J Clin Nutr 95, 1079-1088.
128. Da Costa L, Badawi A & El-Sohemy A (2012) Nutrigenetics and modulation of oxidative stress. Ann Nutr Metab 60, Suppl. 3, 27-36.
129. Riccioni G, Frigiola A, Pasquale S, et al. (2012) Vitamin C and E consumption and coronary heart disease in men. Front Biosci (Elite Ed) 4, 373-380.
130. Hung P, Chen F, Kuang S, et al. (2010) miR-146a induces differentiation of periodontal ligament cells. J Dent Res 89, 252-257.
131. Kim Y, Ku S, Rosenwaks Z, et al. (2010) MicroRNA expression profiles are altered by gonadotropins and vitamin C status during in vitro follicular growth. Reprod Sci 17, 1081-1089.
132. Woodson K, Tangrea J, Barrett M, et al. (1999) Serum a-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 91, 1738-1743. (Pubitemid 29518769)
133. Huang H, Alberg A, Norkus E, et al. (2003) Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157, 335-344. (Pubitemid 36193936)
134. Gridley G, McLaughlin J, Block G, et al. (1992) Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 135, 1083-1092.
135. Longnecker M, Martin-Moreno J, Knekt P, et al. (1992) Serum a-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Natl Cancer Inst 84, 430-435.
136. Banim P, Luben R, McTaggart A, et al. (2013) Dietary antiox-idants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers. Gut 62, 1489-1496.
137. Zhang W, Shu X, Li H, et al. (2012) Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst 104, 1173-1181.
138. Ocké M, Bueno-de-Mesquita H, Feskens E, et al. (1997) Repeated measurements of vegetables, fruits, b-carotene, and vitamins C and E in relation to lung cancer. The Zut-phen Study. Am J Epidemiol 145, 358-365. (Pubitemid 27082035)
139. Gilbert R, Metcalfe C, Fraser W, et al. (2012) Associations of circulating retinol, vitamin E, and 1, 25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade. Cancer Causes Control 23, 1865-1873.
140. Lonn E, Bosch J, Yusuf S, et al. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293, 1338-1347. (Pubitemid 40381486)
141. Miller E, Pastor-Barriuso R, Dalal D, et al. (2005) Meta-Analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 37-46.
142. Rimbach G, Moehring J, Huebbe P, et al. (2010) Gene-regulatory activity of a-tocopherol. Molecules 15, 1746-1761.
143. Esau C, Davis S, Murray S, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98.
144. Elmén J, Lindow M, Silahtaroglu A, et al. (2008) Antagonism of microRNA-122inmicebysystemically administered LNA-Anti-miR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36, 1153-1162. (Pubitemid 351330933)
145. Rayman M (2012) Selenium and human health. Lancet 379, 1256-1268.
146. Rayman M, Blundell-Pound G, Pastor-Barriuso R, et al. (2012) A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adipo-nectin. PLOS ONE 7, e45269.
147. Bleys J, Navas-Acien A & Guallar E (2007) Serum selenium and diabetes in U.S. Adults. Diabetes Care 30, 829-834. (Pubitemid 46562365)
148. Laclaustra M, Navas-Acien A, Stranges S, et al. (2009) Serum selenium concentrations and diabetes in U.S. Adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 117, 1409-1413.
149. Sarveswaran S, Liroff J, Zhou Z, et al. (2010) Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: implication for the treatment of early-stage prostate cancer. Int J Oncol 36, 1419-1428.
150. Hermeking H (2007) p53 enters the microRNA world. Cancer Cell 12, 414-418. (Pubitemid 350046413)
151. Prasad A (2012) Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol 26, 66-69.
152. Ryu M, Langkamp-Henken B, Chang S, et al. (2011) Geno-mic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc Natl Acad Sci U S A 108, 20970-20975.
153. Pogue A, Percy M, Cui J, et al. (2011) Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J Inorg Biochem 105, 1434-1437.
154. Barr I, Smith A, Chen Y, et al. (2012) Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for primary microRNA processing. Proc Natl Acad Sci U S A 109, 1919-1924.
155. Ma Z, Xue Z, Zhang H, et al. (2012) Local and global effects of Mg2+ on Ago and miRNA-target interactions. J Mol Model 18, 3769-3781.
156. Zhang L, Hou D, Chen X, et al. (2012) Exogenous plant miR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22, 107-126.
157. Newmark P, Reddien P, Cebrià F, et al. (2003) Ingestion of bacterially expressed double-stranded RNA inhibits gene expression in planarians. Proc Natl Acad Sci U S A 100, Suppl. 1, 11861-11865. (Pubitemid 37205896)
158. Terenius O, Papanicolaou A, Garbutt J, et al. (2011) RNA interference in Lepidoptera: an overview of successful and unsuccessful studies and implications for experimental design. J Insect Physiol 57, 231-245.
159. Omarov R & Scholthof H (2012) Biological chemistry of virus-encoded suppressors of RNA silencing: an overview. Methods Mol Biol 894, 39-56.
160. Zhou Q, Li M, Wang X, et al. (2012) Immune-related micro-RNAs are abundant in breast milk exosomes. Int J Biol Sci 8, 118-123.
161. Izumi H, Kosaka N, Shimizu T, et al. (2012) Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions. J Dairy Sci 95, 4831-4841.
162. Kosaka N, Izumi H, Sekine K, et al. (2010) MicroRNA as a new immune-regulatory agent in breast milk. Silence 1, 7.
163. Jiang M, Sang X & Hong Z (2012) Beyond nutrients: food-derived microRNAs provide cross-kingdom regulation. Bioessays 34, 280-284.
164. Witwer K, McAlexander M, Queen S, et al. (2013) Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol 10, 1080-1086.
165. Snow J, Hale A, Isaacs S, et al. (2013) Ineffective delivery of diet-derived microRNAs to recipient animal organisms. RNA Biol 10, 1107-1116.
166. Zhang Y, Wiggins B, Lawrence C, et al. (2012) Analysis of plant-derived miRNAs in animal small RNA datasets. BMC Genomics 13, 381.
167. Petrick J, Brower-Toland B, Jackson A, et al. (2013) Safety assessment of food and feed from biotechnology-derived crops employing RNA-mediated gene regulation to achieve desired traits: a scientific review. Regul Toxicol Pharmacol 66, 167-186.